Down-regulation of Bcl-2-interacting protein BAG-1 confers resistance to anti-cancer drugs

https://doi.org/10.1016/S0006-291X(03)00020-2Get rights and content

Abstract

BAG-1 was originally identified as a binding partner of anti-apoptotic factor Bcl-2 [Takayama et al., Cell 80 (1995) 279–284]. Exogenous expression of BAG-1 was reported to confer cells resistance to several stresses [Chen et al., Oncogene 21 (2002) 7050]. We have obtained human cervical cancer HeLa cells with down-regulated BAG-1 levels by using a highly specific and efficient RNA interference approach. Surprisingly, cells with down-regulated BAG-1 exhibited significantly lower sensitivity against several anti-cancer drugs than parental cells expressing normal levels of the protein. Furthermore, growth rate of the cells was reduced when BAG-1 was down-regulated. Activity of ERK pathway appeared to be decreased in BAG-1 down-regulated cells, as shown by the reduced phosphorylation of ERK1/2 proteins. Taken together resistance against anti-cancer drugs acquired by BAG-1 down-regulated cells may well be accounted for by the retardation of cell cycle progression, implicating the importance of BAG-1 in cell growth regulation.

Section snippets

Materials and methods

Antibodies. The monoclonal antibody against BAG-1 was provided by S. Takayama (The Burnham Institute, CA). The antibodies against apoptosis-related genes such as Bcl-2 and p53 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Hsp70 and anti-Hsp90 monoclonal antibodies were obtained from Transduction Laboratories (Lexington, KY). Phospho-ERK monoclonal antibody and ERK polyclonal antibody were obtained from Cell Signaling Technology (Beverly, MA).

Anti-cancer and ER stress drugs.

SiRNA B246 effectively down-regulates BAG-1 expression

In order to find appropriate sites on the BAG-1 mRNA for siRNA in down-regulating BAG-1, three different potential target sites were selected, as depicted in Fig. 1A and in Table 1, and 21mer siRNAs were synthesized by in vitro transcription, as described in Materials and methods. Each siRNA was transfected into human cervical carcinoma line HeLa cells, and the cells were harvested two and three days after transfection. Transfected cells were split into two at day three, and one aliquot was

Discussion

BAG-1 is a multi-functional anti-apoptotic protein recently identified as a Bcl-2 interacting protein [1]. BAG-1 enhanced the anti-apoptotic function of Bcl-2 when the two genes were co-transfected into a human lymphoid cell line, Jurkat cells [1]. Furthermore, it was reported that cells overexpressing BAG-1 exhibit resistance against a variety of external stresses. Overexpression of BAG-1 protects rat liver cells from ischemia/reperfusion injury [27]. Several human cervical cancer cell lines

Acknowledgements

We thank S. Takayama for BAG-1 antibody and members of our laboratory for critical discussion.

References (32)

  • M. Zeiner et al.

    A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning

    Proc. Natl. Acad. Sci. USA

    (1995)
  • S. Takayama et al.

    BAG-1 modulates the chaperone activity of Hsp70/Hsc70

    EMBO J.

    (1997)
  • M. Zeiner et al.

    Mammalian protein RAP46: an interaction partner and modulator of 70 kDa heat shock proteins

    EMBO J.

    (1997)
  • J. Hohfeld et al.

    GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1

    EMBO J.

    (1997)
  • J. Hohfeld

    Regulation of the heat shock conjugate Hsc70 in the mammalian cell: the characterization of the anti-apoptotic protein BAG-1 provides novel insights

    Biol. Chem.

    (1998)
  • M. Zeiner et al.

    The Hsp70-associating protein Hap46 binds to DNA and stimulates transcription

    Proc. Natl. Acad. Sci. USA

    (1999)
  • Cited by (0)

    Abbreviations: RNAi, RNA interference; siRNA, small interfering RNA; Hsp, heat-shock protein; IC50, concentration inhibiting 50%; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

    View full text